Indian Pharmacopoeia Commission – Autonomous Institution of the Ministry of Health and Family Welfare, Government of India
Government scheme — a structured programme with defined beneficiaries, budget allocation, and delivery mechanisms. The primary instrument for delivering welfare and development outcomes.
Summary
The National Accreditation Board for Hospitals and Healthcare Providers (NABH) and the Indian Pharmacopoeia Commission (IPC) have established a collaborative initiative aimed at strengthening the reporting mechanisms for Adverse Drug Reactions (ADR) and Medical Device Adverse Events (MDAE) within NABH-accredited hospitals.
Key Facts
Type Scheme
Source NABH
Published Wednesday, 22 April 2026
Affected Population 1.4 billion citizens, 5 million healthcare workers
Key Numbers
Health budget: Rs 90,958 crore (2025-26)
Target: 2.5% of GDP public health spending
1.5 lakh Health & Wellness Centres planned
Net-zero target: 2070
Key Authorities
Key Stakeholders
Government Context
NDA III BJP-led NDA
Left Centre Right